Intellectual Property India Publishes Patent Application for Design, Development, And Optimization Of A Lyophilized Liposomal Amphotericin B Formulation Using Box–behnken Experimental Design Incorporating Hspc, Cholesterol, And Trehalose For Enhanced Entrapment Efficiency, Controlled Particle Size Distribution, Reduced Hemolytic Toxicity, And Improved Systemic Antifungal Performance

MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611055904 A) filed by Prevesh Kumar; Rakesh Arya; Somesh Thapliyal; Chirayu Sharma; Ragini Bose; Kunal Narayanbhai Patel; Sumana Roy; Sanchari Bhattacharya; Priyanka Ray; Keyur Shankarlal Patel; Switi Buch; and Pinki Biswas on May 01, 2026, for Design, Development, And Optimization Of A Lyophilized Liposomal Amphotericin B Formulation Using Box–behnken Experimental Design Incorporating Hspc, Cholesterol, And Trehalose For Enhanced Entrapment Efficiency, Controlled Particle Size Distribution, Reduced Hemolytic Toxicity, And Improved Systemic Antifungal Performance.

Inventors include Prevesh Kumar; Rakesh Arya; Somesh Thapliyal; Chirayu Sharma; Ragin...